Non-invasive CT radiomic biomarkers predict microsatellite stability status in colorectal cancer: a multicenter validation study.
Colorectal neoplasms
DNA mismatch repair
Machine learning
Microsatellite instability
Radiomics
Journal
European radiology experimental
ISSN: 2509-9280
Titre abrégé: Eur Radiol Exp
Pays: England
ID NLM: 101721752
Informations de publication
Date de publication:
26 Aug 2024
26 Aug 2024
Historique:
received:
29
04
2024
accepted:
30
05
2024
medline:
26
8
2024
pubmed:
26
8
2024
entrez:
26
8
2024
Statut:
epublish
Résumé
Microsatellite instability (MSI) status is a strong predictor of response to immunotherapy of colorectal cancer. Radiogenomic approaches promise the ability to gain insight into the underlying tumor biology using non-invasive routine clinical images. This study investigates the association between tumor morphology and the status of MSI versus microsatellite stability (MSS), validating a novel radiomic signature on an external multicenter cohort. Preoperative computed tomography scans with matched MSI status were retrospectively collected for 243 colorectal cancer patients from three hospitals: Seoul National University Hospital (SNUH); Netherlands Cancer Institute (NKI); and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Italy (INT). Radiologists delineated primary tumors in each scan, from which radiomic features were extracted. Machine learning models trained on SNUH data to identify MSI tumors underwent external validation using NKI and INT images. Performances were compared in terms of area under the receiving operating curve (AUROC). We identified a radiomic signature comprising seven radiomic features that were predictive of tumors with MSS or MSI (AUROC 0.69, 95% confidence interval [CI] 0.54-0.84, p = 0.018). Integrating radiomic and clinical data into an algorithm improved predictive performance to an AUROC of 0.78 (95% CI 0.60-0.91, p = 0.002) and enhanced the reliability of the predictions. Differences in the radiomic morphological phenotype between tumors MSS or MSI could be detected using radiogenomic approaches. Future research involving large-scale multicenter prospective studies that combine various diagnostic data is necessary to refine and validate more robust, potentially tumor-agnostic MSI radiogenomic models. Noninvasive radiomic signatures derived from computed tomography scans can predict MSI in colorectal cancer, potentially augmenting traditional biopsy-based methods and enhancing personalized treatment strategies. Noninvasive CT-based radiomics predicted MSI in colorectal cancer, enhancing stratification. A seven-feature radiomic signature differentiated tumors with MSI from those with MSS in multicenter cohorts. Integrating radiomic and clinical data improved the algorithm's predictive performance.
Sections du résumé
BACKGROUND
BACKGROUND
Microsatellite instability (MSI) status is a strong predictor of response to immunotherapy of colorectal cancer. Radiogenomic approaches promise the ability to gain insight into the underlying tumor biology using non-invasive routine clinical images. This study investigates the association between tumor morphology and the status of MSI versus microsatellite stability (MSS), validating a novel radiomic signature on an external multicenter cohort.
METHODS
METHODS
Preoperative computed tomography scans with matched MSI status were retrospectively collected for 243 colorectal cancer patients from three hospitals: Seoul National University Hospital (SNUH); Netherlands Cancer Institute (NKI); and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Italy (INT). Radiologists delineated primary tumors in each scan, from which radiomic features were extracted. Machine learning models trained on SNUH data to identify MSI tumors underwent external validation using NKI and INT images. Performances were compared in terms of area under the receiving operating curve (AUROC).
RESULTS
RESULTS
We identified a radiomic signature comprising seven radiomic features that were predictive of tumors with MSS or MSI (AUROC 0.69, 95% confidence interval [CI] 0.54-0.84, p = 0.018). Integrating radiomic and clinical data into an algorithm improved predictive performance to an AUROC of 0.78 (95% CI 0.60-0.91, p = 0.002) and enhanced the reliability of the predictions.
CONCLUSION
CONCLUSIONS
Differences in the radiomic morphological phenotype between tumors MSS or MSI could be detected using radiogenomic approaches. Future research involving large-scale multicenter prospective studies that combine various diagnostic data is necessary to refine and validate more robust, potentially tumor-agnostic MSI radiogenomic models.
RELEVANCE STATEMENT
CONCLUSIONS
Noninvasive radiomic signatures derived from computed tomography scans can predict MSI in colorectal cancer, potentially augmenting traditional biopsy-based methods and enhancing personalized treatment strategies.
KEY POINTS
CONCLUSIONS
Noninvasive CT-based radiomics predicted MSI in colorectal cancer, enhancing stratification. A seven-feature radiomic signature differentiated tumors with MSI from those with MSS in multicenter cohorts. Integrating radiomic and clinical data improved the algorithm's predictive performance.
Identifiants
pubmed: 39186200
doi: 10.1186/s41747-024-00484-8
pii: 10.1186/s41747-024-00484-8
doi:
Types de publication
Journal Article
Multicenter Study
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
98Informations de copyright
© 2024. The Author(s).
Références
Gilson P, Merlin J-L, Harlé A (2021) Detection of microsatellite instability: state of the art and future applications in circulating tumour DNA (ctDNA). Cancers 13. https://doi.org/10.3390/cancers13071491
Nojadeh JN, Behrouz Sharif S, Sakhinia E (2018) Microsatellite instability in colorectal cancer. EXCLI J 17:159–168. https://doi.org/10.17179/excli2017-948
doi: 10.17179/excli2017-948
pubmed: 29743854
pmcid: 5938532
Sinicrope FA, Sargent DJ (2012) Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res 18:1506–1512. https://doi.org/10.1158/1078-0432.CCR-11-1469
doi: 10.1158/1078-0432.CCR-11-1469
pubmed: 22302899
pmcid: 3306518
Golia Pernicka JS, Gagniere J, Chakraborty J et al (2019) Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluation. Abdom Radiol (NY) 44:3755–3763. https://doi.org/10.1007/s00261-019-02117-w
doi: 10.1007/s00261-019-02117-w
pubmed: 31250180
Zeinalian M, Hashemzadeh-Chaleshtori M, Salehi R, Emami MH (2018) Clinical aspects of microsatellite instability testing in colorectal cancer. Adv Biomed Res 7:28. https://doi.org/10.4103/abr.abr_185_16
doi: 10.4103/abr.abr_185_16
pubmed: 29531926
pmcid: 5841008
Merok MA, Ahlquist T, Røyrvik EC et al (2013) Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol 24:1274–1282. https://doi.org/10.1093/annonc/mds614
doi: 10.1093/annonc/mds614
pubmed: 23235802
Zaanan A, Bachet J-B, André T, Sinicrope FA (2014) Prognostic impact of deficient DNA mismatch repair and mutations in KRAS, and BRAFV600E in patients with lymph node-positive colon cancer. Curr Colorectal Cancer Rep 10:346–353. https://doi.org/10.1007/s11888-014-0237-2
doi: 10.1007/s11888-014-0237-2
pubmed: 25386108
pmcid: 4224319
Sinicrope FA, Mahoney MR, Smyrk TC et al (2013) Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy. J Clin Oncol 31:3664–3672. https://doi.org/10.1200/JCO.2013.48.9591
doi: 10.1200/JCO.2013.48.9591
pubmed: 24019539
pmcid: 3789216
Klingbiel D, Saridaki Z, Roth AD et al (2015) Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial. Ann Oncol 26:126–132. https://doi.org/10.1093/annonc/mdu499
doi: 10.1093/annonc/mdu499
pubmed: 25361982
Hasan S, Renz P, Wegner RE et al (2020) Microsatellite instability (MSI) as an independent predictor of pathologic complete response (PCR) in locally advanced rectal cancer: a national cancer database (NCDB) analysis. Ann Surg 271:716–723. https://doi.org/10.1097/SLA.0000000000003051
doi: 10.1097/SLA.0000000000003051
pubmed: 30216221
Li K, Luo H, Huang L et al (2020) Microsatellite instability: a review of what the oncologist should know. Cancer Cell Int 20:16. https://doi.org/10.1186/s12935-019-1091-8
doi: 10.1186/s12935-019-1091-8
pubmed: 31956294
pmcid: 6958913
Seligmann JF (2020) FOxTROT: neoadjuvant FOLFOX chemotherapy with or without panitumumab (Pan) for patients (pts) with locally advanced colon cancer (CC). J Clin Orthod 38:4013–4013. https://doi.org/10.1200/JCO.2020.38.15_suppl.4013
doi: 10.1200/JCO.2020.38.15_suppl.4013
Yunlong W, Tongtong L, Hua Z (2022) The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency. Cancer Med. https://doi.org/10.1002/cam4.5076
Mlecnik B, Bindea G, Angell HK et al (2016) Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 44:698–711. https://doi.org/10.1016/j.immuni.2016.02.025
doi: 10.1016/j.immuni.2016.02.025
pubmed: 26982367
Llosa NJ, Cruise M, Tam A et al (2015) The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov 5:43–51. https://doi.org/10.1158/2159-8290.CD-14-0863
doi: 10.1158/2159-8290.CD-14-0863
pubmed: 25358689
Le DT, Uram JN, Wang H et al (2015) PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372:2509–2520. https://doi.org/10.1056/NEJMoa1500596
doi: 10.1056/NEJMoa1500596
pubmed: 26028255
pmcid: 4481136
Timmermann B, Kerick M, Roehr C et al (2010) Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS One 5:e15661. https://doi.org/10.1371/journal.pone.0015661
doi: 10.1371/journal.pone.0015661
pubmed: 21203531
pmcid: 3008745
Takei S, Kawazoe A, Shitara K (2022) The new era of immunotherapy in gastric cancer. Cancers 14. https://doi.org/10.3390/cancers14041054
Motta R, Cabezas-Camarero S, Torres-Mattos C et al (2021) Immunotherapy in microsatellite instability metastatic colorectal cancer: current status and future perspectives. Transl Res 7:511–522. https://doi.org/10.18053/jctres.07.202104.016
doi: 10.18053/jctres.07.202104.016
Hidaka Y, Arigami T, Osako Y et al (2022) Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report. World J Surg Oncol 20:193. https://doi.org/10.1186/s12957-022-02661-8
doi: 10.1186/s12957-022-02661-8
pubmed: 35689267
pmcid: 9185925
Chao J, Fuchs CS, Shitara K et al (2021) Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials. JAMA Oncol 7:895–902. https://doi.org/10.1001/jamaoncol.2021.0275
doi: 10.1001/jamaoncol.2021.0275
pubmed: 33792646
pmcid: 8017478
Weis LN, Tolaney SM, Barrios CH, Barroso-Sousa R (2021) Tissue-agnostic drug approvals: how does this apply to patients with breast cancer? NPJ Breast Cancer 7:120. https://doi.org/10.1038/s41523-021-00328-3
doi: 10.1038/s41523-021-00328-3
pubmed: 34518552
pmcid: 8437983
Chalabi M, Fanchi LF, Dijkstra KK et al (2020) Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med 26:566–576. https://doi.org/10.1038/s41591-020-0805-8
doi: 10.1038/s41591-020-0805-8
pubmed: 32251400
André T, Shiu K-K, Kim TW et al (2020) Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med 383:2207–2218. https://doi.org/10.1056/NEJMoa2017699
doi: 10.1056/NEJMoa2017699
pubmed: 33264544
Fan A, Wang B, Wang X et al (2021) Immunotherapy in colorectal cancer: current achievements and future perspective. Int J Biol Sci 17:3837–3849. https://doi.org/10.7150/ijbs.64077
doi: 10.7150/ijbs.64077
pubmed: 34671202
pmcid: 8495390
Diaz Jr LA, Shiu K-K, Kim T-W et al (2022) Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol 23:659–670. https://doi.org/10.1016/S1470-2045(22)00197-8
doi: 10.1016/S1470-2045(22)00197-8
pubmed: 35427471
pmcid: 9533375
Latham A, Srinivasan P, Kemel Y et al (2019) Microsatellite instability is associated with the presence of lynch syndrome pan-cancer. J Clin Oncol 37:286–295. https://doi.org/10.1200/JCO.18.00283
doi: 10.1200/JCO.18.00283
pubmed: 30376427
Hause RJ, Pritchard CC, Shendure J, Salipante SJ (2016) Classification and characterization of microsatellite instability across 18 cancer types. Nat Med 22:1342–1350. https://doi.org/10.1038/nm.4191
doi: 10.1038/nm.4191
pubmed: 27694933
Fan S, Li X, Cui X et al (2019) Computed tomography-based radiomic features could potentially predict microsatellite instability status in stage II colorectal cancer: a preliminary study. Acad Radiol 26:1633–1640. https://doi.org/10.1016/j.acra.2019.02.009
doi: 10.1016/j.acra.2019.02.009
pubmed: 30929999
Kocak B, Baessler B, Bakas S et al (2023) CheckList for evaluation of radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII. Insights Imaging 14:75. https://doi.org/10.1186/s13244-023-01415-8
doi: 10.1186/s13244-023-01415-8
pubmed: 37142815
pmcid: 10160267
Nearly Raw Raster Data format description. https://teem.sourceforge.net/nrrd/ . Accessed 27 May 2024
Welcome to pyradiomics documentation! — pyradiomics v3.1.0rc2.post5+g6a761c4 documentation. https://pyradiomics.readthedocs.io/en/latest/ . Accessed 27 May 2024
Zwanenburg A, Vallières M, Abdalah MA et al (2020) The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 295:328–338. https://doi.org/10.1148/radiol.2020191145
doi: 10.1148/radiol.2020191145
pubmed: 32154773
van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77:e104–e107. https://doi.org/10.1158/0008-5472.CAN-17-0339
doi: 10.1158/0008-5472.CAN-17-0339
pubmed: 29092951
pmcid: 5672828
Effrosynidis D, Arampatzis A (2021) An evaluation of feature selection methods for environmental data. Ecol Inform 61:101224. https://doi.org/10.1016/j.ecoinf.2021.101224
doi: 10.1016/j.ecoinf.2021.101224
Pes B (2020) Ensemble feature selection for high-dimensional data: a stability analysis across multiple domains. Neural Comput Appl 32:5951–5973. https://doi.org/10.1007/s00521-019-04082-3
doi: 10.1007/s00521-019-04082-3
Bolón-Canedo V, Alonso-Betanzos A (2019) Ensembles for feature selection: a review and future trends. Inf Fusion 52:1–12. https://doi.org/10.1016/j.inffus.2018.11.008
doi: 10.1016/j.inffus.2018.11.008
Bodalal Z, Bogveradze N, Ter Beek LC et al (2023) Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases. Insights Imaging 14:133. https://doi.org/10.1186/s13244-023-01474-x
doi: 10.1186/s13244-023-01474-x
pubmed: 37477715
pmcid: 10361926
Ahmadian M, Bodalal Z, van der Hulst HJ et al (2024) Overcoming data scarcity in radiomics/radiogenomics using synthetic radiomic features. Comput Biol Med 174:108389. https://doi.org/10.1016/j.compbiomed.2024.108389
doi: 10.1016/j.compbiomed.2024.108389
pubmed: 38593640
Zhang Y, Oikonomou A, Wong A et al (2017) Radiomics-based prognosis analysis for non-small cell lung cancer. Sci Rep 7:46349. https://doi.org/10.1038/srep46349
doi: 10.1038/srep46349
pubmed: 28418006
pmcid: 5394465
Sanduleanu S, Jochems A, Upadhaya T et al (2020) Non-invasive imaging prediction of tumor hypoxia: a novel developed and externally validated CT and FDG-PET-based radiomic signatures. Radiother Oncol 153:97–105. https://doi.org/10.1016/j.radonc.2020.10.016
doi: 10.1016/j.radonc.2020.10.016
pubmed: 33137396
Li Z, Dai H, Liu Y et al (2021) Radiomics analysis of multi-sequence MR images for predicting microsatellite instability status preoperatively in rectal cancer. Front Oncol 11:697497. https://doi.org/10.3389/fonc.2021.697497
doi: 10.3389/fonc.2021.697497
pubmed: 34307164
pmcid: 8293900
Jing G, Chen Y, Ma X et al (2022) Predicting mismatch-repair status in rectal cancer using multiparametric MRI-based radiomics models: a preliminary study. Biomed Res Int 2022: https://doi.org/10.1155/2022/6623574
Le TT, Fu W, Moore JH (2020) Scaling tree-based automated machine learning to biomedical big data with a feature set selector. Bioinformatics 36:250–256. https://doi.org/10.1093/bioinformatics/btz470
doi: 10.1093/bioinformatics/btz470
pubmed: 31165141
Olson RS, Urbanowicz RJ, Andrews PC et al (2016) Automating Biomedical Data Science Through Tree-Based Pipeline Optimization. In: Applications of Evolutionary Computation. Springer International Publishing, 123–137
Olson RS, Bartley N, Urbanowicz RJ, Moore JH (2016) Evaluation of a Tree-based Pipeline Optimization Tool for Automating Data Science. In: Proceedings of the Genetic and Evolutionary Computation Conference 2016. Association for Computing Machinery, New York, NY, USA, 485–492
Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29–36. https://doi.org/10.1148/radiology.143.1.7063747
doi: 10.1148/radiology.143.1.7063747
pubmed: 7063747
Greenson JK, Huang S-C, Herron C et al (2009) Pathologic predictors of microsatellite instability in colorectal cancer. Am J Surg Pathol 33:126–133. https://doi.org/10.1097/PAS.0b013e31817ec2b1
doi: 10.1097/PAS.0b013e31817ec2b1
pubmed: 18830122
pmcid: 3500028
Jenkins MA, Hayashi S, O’Shea A-M et al (2007) Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology 133:48–56. https://doi.org/10.1053/j.gastro.2007.04.044
doi: 10.1053/j.gastro.2007.04.044
pubmed: 17631130
Hong EK, Chalabi M, Landolfi F et al (2022) Colon cancer CT staging according to mismatch repair status: comparison and suggestion of imaging features for high-risk colon cancer. Eur J Cancer 174:165–175. https://doi.org/10.1016/j.ejca.2022.06.060
doi: 10.1016/j.ejca.2022.06.060
pubmed: 36029713
Coppola F, Mottola M, Lo Monaco S et al (2021) The Heterogeneity of Skewness in T2W-Based Radiomics Predicts the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Diagnostics (Basel) 11. https://doi.org/10.3390/diagnostics11050795
Miles KA, Ganeshan B, Hayball MP (2013) CT texture analysis using the filtration-histogram method: what do the measurements mean? Cancer Imaging 13:400–406. https://doi.org/10.1102/1470-7330.2013.9045
doi: 10.1102/1470-7330.2013.9045
pubmed: 24061266
pmcid: 3781643
Thomas HMT, Wang HYC, Varghese AJ et al (2024) Reproducibility in radiomics: a comparison of feature extraction methods and two independent datasets. Appl Sci 166: https://doi.org/10.3390/app13127291
Traverso A, Wee L, Dekker A, Gillies R (2018) Repeatability and reproducibility of radiomic features: a systematic review. Int J Radiat Oncol Biol Phys 102:1143–1158. https://doi.org/10.1016/j.ijrobp.2018.05.053
doi: 10.1016/j.ijrobp.2018.05.053
pubmed: 30170872
pmcid: 6690209
Li J, Yang Z, Xin B et al (2021) Quantitative prediction of microsatellite instability in colorectal cancer with preoperative PET/CT-based radiomics. Front Oncol 11:702055. https://doi.org/10.3389/fonc.2021.702055
doi: 10.3389/fonc.2021.702055
pubmed: 34367985
pmcid: 8339969
Zhang W, Huang Z, Zhao J et al (2021) Development and validation of magnetic resonance imaging-based radiomics models for preoperative prediction of microsatellite instability in rectal cancer. Ann Transl Med 9:134. https://doi.org/10.21037/atm-20-7673
doi: 10.21037/atm-20-7673
pubmed: 33569436
pmcid: 7867944
Baran B, Mert Ozupek N, Yerli Tetik N et al (2018) Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterol Res Pract 11:264–273. https://doi.org/10.14740/gr1062w
doi: 10.14740/gr1062w
Ying M, Pan J, Lu G et al (2022) Development and validation of a radiomics-based nomogram for the preoperative prediction of microsatellite instability in colorectal cancer. BMC Cancer 22:524. https://doi.org/10.1186/s12885-022-09584-3
doi: 10.1186/s12885-022-09584-3
pubmed: 35534797
pmcid: 9087961
Yuan H, Peng Y, Xu X et al (2022) A tumoral and peritumoral CT-based radiomics and machine learning approach to predict the microsatellite instability of rectal carcinoma. Cancer Manag Res 14:2409–2418. https://doi.org/10.2147/CMAR.S377138
doi: 10.2147/CMAR.S377138
pubmed: 35971393
pmcid: 9375564
Kim S, Lee J-H, Park EJ et al (2023) Prediction of microsatellite instability in colorectal cancer using a machine learning model based on PET/CT radiomics. Yonsei Med J 64:320–326. https://doi.org/10.3349/ymj.2022.0548
doi: 10.3349/ymj.2022.0548
pubmed: 37114635
pmcid: 10151228
Pei Q, Yi X, Chen C et al (2022) Pre-treatment CT-based radiomics nomogram for predicting microsatellite instability status in colorectal cancer. Eur Radiol 32:714–724. https://doi.org/10.1007/s00330-021-08167-3
doi: 10.1007/s00330-021-08167-3
pubmed: 34258636
Li Z, Zhang J, Zhong Q et al (2023) Development and external validation of a multiparametric MRI-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer: a retrospective multicenter study. Eur Radiol 33:1835–1843. https://doi.org/10.1007/s00330-022-09160-0
doi: 10.1007/s00330-022-09160-0
pubmed: 36282309
Chen X, He L, Li Q et al (2023) Non-invasive prediction of microsatellite instability in colorectal cancer by a genetic algorithm-enhanced artificial neural network-based CT radiomics signature. Eur Radiol 33:11–22. https://doi.org/10.1007/s00330-022-08954-6
doi: 10.1007/s00330-022-08954-6
pubmed: 35771245
Cao Y, Zhang G, Zhang J et al (2021) Predicting microsatellite instability status in colorectal cancer based on triphasic enhanced computed tomography radiomics signatures: a multicenter study. Front Oncol 11:687771. https://doi.org/10.3389/fonc.2021.687771
doi: 10.3389/fonc.2021.687771
pubmed: 34178682
pmcid: 8222982
Park JE, Park SY, Kim HJ, Kim HS (2019) Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives. Korean J Radiol 20:1124–1137. https://doi.org/10.3348/kjr.2018.0070
doi: 10.3348/kjr.2018.0070
pubmed: 31270976
pmcid: 6609433
Jha AK, Mithun S, Jaiswar V et al (2021) Repeatability and reproducibility study of radiomic features on a phantom and human cohort. Sci Rep 11:2055. https://doi.org/10.1038/s41598-021-81526-8
doi: 10.1038/s41598-021-81526-8
pubmed: 33479392
pmcid: 7820018
Zhao B (2021) Understanding sources of variation to improve the reproducibility of radiomics. Front Oncol 11:633176. https://doi.org/10.3389/fonc.2021.633176
doi: 10.3389/fonc.2021.633176
pubmed: 33854969
pmcid: 8039446